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In the rat, mesenteric lymphadenectomy allows collection of dendritic cells (DC) derived from 
the small intestine after cannulation of the thoracic duct. We prepared rats this way and administered 
antigens by oral feeding or intraintestinal injection. DC enriched from the thoracic duct lymph 
collected over the first 24 h from these animals are able to stimulate sensitized T  cells in vitro 
and to prime popliteal lymph node CD4 + T cells after footpad injection, while B and T cells 
from the same thoracic duct lymph are inert in priming. 500 or less DC pulsed in vitro with 
antigen can prime T  cells in vivo, whereas 100 times more B cells or macrophages pulsed in 
vitro are quite inert. I mg of ovalbumin administered orally is sufficient to load DC for in vivo 
priming of T cells. Antigen could not be detected directly in DC but was present in macrophages 
in the lamina propria. Direct presentation of antigen by DC to T  cells was demonstrated by 
injecting Ft recipients with parental DC and showing restriction of T cell sensitization to the 
major histocompatibility complex of the injected DC.  Antigen-bearing DC do not induce a 
detectable primary antibody response but a small secondary antibody response can be detected 
after a boosting injection. These results show that acquisition of antigens by DC in the intestine 
is very similar to what occurs in vitro or in other tissues, suggesting that there may be no special 
difference in antigen handling at mucosal surfaces. One implication of these results is that hypotheses 
designed to explain oral tolerance must take into account the presence of immunostimulatory, 
antigen-bearing DC in animals  that have received oral antigens. 
T 
he intestine is continually exposed to foreign antigens, 
but whereas it is critical that protective immune responses 
are made to potential pathogens, it is equally important that 
hypersensitivity responses are not made to dietary antigens. 
Antigens introduced into the small intestine can induce both 
local and systemic responses and in some circumstances may 
induce local immunity but systemic tolerance (1). The mech- 
anisms underlying both stimulatory and tolerogenic responses 
are not understood and, in particular,  the role of differential 
antigen handling and presentation has been rarely investigated. 
Several distinct potential APC are present in the small intes- 
tine. These include macrophages (2), B lymphocytes (3), ep- 
ithelial cells (4), and dendritic cells (DC) 1 (5, 6), and it has 
been suggested that regulation of intestinal immune responses 
may be in part dependent on the nature of the cells involved 
in presentation to T cells, in particular that presentation by 
epithelial cells (7) or supposed I-J-positive APC (8) may be 
responsible for the generation of suppressor cells. 
1  Abbreviations used in this t~Fer: DC, dendritic cells; HRP, horseradish 
peroxidase; L-DC, lymph-borne DC; MLNX, mesenteric lymphadenec- 
tomy; XTDL, thoracic duct lymph from lymphadenectomized rat. 
There is, however, increasing evidence that at least in ro- 
dents, DC are the only APC able to activate resting T cells 
efficiently and that other APC are able to present antigens 
only to activated T cells (9). One of the main functions of 
DC in vivo is thought to be the acquisition of antigens in 
peripheral tissues and their transport to draining lymph nodes 
for presentation as processed peptides to T lymphocytes. Thus, 
Mayrhofer et al. (10) showed that during a Salmonella infec- 
tion, specific antigens were present in cells with the mor- 
phology of DC in lymph draining the intestine. Macatonia 
et al. (11) showed that after skin painting with FITC, DC 
in the draining lymph node expressed FITC, could stimulate 
sensitized T cells, and could induce sensitivity in a naive re- 
cipient. Bujdoso et al. (12) showed that after subcutaneous 
injection of antigen, DC in lymph draining the site of injec- 
tion could present the antigen to sensitized T cells. Crowley 
et al. (13) showed that after intravenous injection of antigen, 
DC were the only cells in the spleen that contained immuno- 
genic fragments. 
We have developed a model in which after  mesenteric 
lymphadenectomy  (MLNX), DC derived from the small in- 
testine can be collected in thoracic duct lymph (XTDL) (14). 
We have shown that after the direct injection of soluble an- 
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quire the antigen and migrate into peripheral lymph, and that 
these lymph-borne DC (L-DC) can present the antigen to 
sensitized T  cells in a MHC class II-restricted, CD4-depen- 
dent manner  (15). 
In this paper we have compared the effects of giving an- 
tigen orally or intraintestinaUy upon its acquisition by L-DC, 
and have examined the ability of such L-DC to induce im- 
mune  responses  in  naive animals  in comparison with  DC 
pulsed with antigen in vitro. We show that oral antigen is 
acquired efficiently by intestinal DC, but not by other cells 
present in lymph, that antigen-bearing L-DC but not B cells 
or macrophages can prime naive T  cells directly in vivo, and 
that such L-DC do not induce detectable primary antibody 
synthesis although  weak secondary antibody responses are 
seen after a boosting injection. One implication of these results 
is that  hypotheses designed  to explain oral tolerance must 
take into account the presence of immunostimulatory, antigen- 
bearing  DC  in animals  that  have received oral antigens. 
Materials and Methods 
Animals.  Rats were specific pathogen-free inbred strains bred 
in the MRC Cellular Immunology Unit, Sir William Dunn School 
of Pathology. The strains used were PVG-RT1  u, PVG-KT1  c, DA- 
ILTP, and (PVG-RT1  u  x  PVG KTlc)F1. 
Surgical Procedures.  MLNX and thoracic duct cannulation were 
carried out as described previously (14). 
Antigens.  OVA (grade v) and horseradish peroxidase (HRP; for 
immunization, type VI-A; for pulsing, type II) were from Sigma 
Chemical Co. (St.  Louis,  MO). 
Pulsing Cells with Antigens In Vitrc~  Cells were incubated with 
OVA or HRP (1 mg/ml) in RPMI 1640 containing 10% FCS, 1% 
sodium pyruvate,  and  10 -s  M  mercaptoethanol (complete me- 
dium) at 37~  for 2.5-3 h. The pulsed cells were washed three 
times with KPMI 1640 plus 10% FCS and resuspended in PBS 
before use. 
In Vivo Antigen Administration.  In vivo antigen administration 
was carried out orally by gastric intubation of anesthetized rats 
or by injecting antigens directly into the gut lumen of MLNX 
rats at laparotomy. 1-30 mg OVA or HKP in 2 ml PBS was intro- 
duced to MLNX PVG rats via gastric intubation or intraintestinal 
injection (15). TDL cells were collected overnight after antigen ad- 
ministration. 
Immunization with Cells Pulsed with Antigens.  Different numbers 
of antigen-poised cells resuspended in PBS were injected into the 
hind footpads of naive PVG rats (100/~l/footpad). 10 d later, cell 
preparations were made from the popliteal lymph nodes and used 
as a source of primed lymph node ceils in an antigen presentation 
assay. 
Immunization with Protein Antigens.  Antigen in PBS (2 mg/ml) 
was emulsified with an equal volume of CFA (Sigma Chemical Co.). 
Rats were injected in the hind footpads with 100/~1 emulsion con- 
taining 100/~g antigen. They were used as a source of antigen- 
primed spleen cells 12-20 d later. 
Veiled L,  DC.  bDC were enriched from XTDL by a singie-step 
density separation. XTDL resuspended in KPMI 1640 plus 10% 
FCS (at a concentration of 5-10  x  106/ml) were overlaid  over 
14.5% metrizamide solution and centrifuged at 400 g for 20 min. 
The interface cells contained 60-80% bDC. The major contaminat- 
ing  cells  were B  lymphocytes. There were g1%  macrophages 
present as identified by morphology and the ability to phagoeytose 
opsonized SRBC. 
Peritoneal Macrophages.  15 ml cold PBS was injected into the 
peritoneal cavity. The abdomen was massaged  and then opened. 
The cell suspension  was collected by pipetting. The call suspen- 
sions normally contained 70% macrophages. 
T Cells.  XTDL or spleen cells were incubated with OX6 (anti- 
In) (16) and OX12 (anti-Ig K) (17) for 40 min at 4~  After washing 
three times they were mixed with a 5% SRBC suspension coated 
with rabbit anti-mouse Ig antibody (Sigma  Chemical Co.), ro- 
tated at 4~  for 20 rain, and then separated by centrifugation over 
Isopaque-Ficoll. The interface contained ~90% T cells as identified 
by flow cytometry or immunocytochemistry. 
B Cells.  B cells were enriched by the rosetting technique de- 
scribed above. They were purified from XTDL cells or spleen cells 
by depleting OX19 (anti-CD5)-  (18), OX52 (pan T)- (19), and 
W3/25  (anti-CD4)-  (20)  positive  cells. The purity was  usually 
85-90%. 
Popliteal Lymph Node Cells.  Popliteal lymph cells were obtained 
by teasing and were washed two times with  RPMI  1640 plus 
0.1% BSA. 
Antigen Presentation Assay.  Assays  were performed in triplicate 
in 96-well round-bottomed tissue culture plates (Flow Laborato- 
ries,  McLean,  VA). For antigen presentation to sensitized  spleen 
T  cells, 2  x  1@ OVA-CFA-primed  spleen cells in complete cul- 
ture medium (containing 10% FCS) were cultured for 108 h in 
a total volume of 0.2 ml in the presence  of bDC from the rats 
challenged with OVA orally or intraintestinally (15). To measure 
the ability of antigen-pulsed cells to prime naive recipients,  2  x 
10  S draining popliteal lymph node ceils were cultured for 120 h 
in complete culture medium (10% FCS was replaced with 5% dark 
agouti rat serum) in the presence of antigens (OVA or HRP). All 
the cultures were carried out at 37~  in an atmosphere of 5% 
CO2 in air. [3H]Thymidine (Amersham Corp.) (0.5 p.ci/well) was 
added to cultures 16 h before harvesting with a cell harvester (Ska- 
tron, Newmarket, England) and uptake was measured by scintilla- 
tion counting. Data were expressed as mean gross counts per minute. 
Immunocytochemistry.  FITC-labeled  canine  albumin  (Sigma 
Chemical Co.) was injected intraintestinally,  and 1, 3, and 6 h later, 
tissues were taken from the small intestine and frozen in OCT com- 
pound (Tissue Tek, Elkhart, IN). Cryostat sections were stained 
with OX6 (anti-rat class II) or OX62 (21; a kind gift from Dr. 
M. Brenan, MRC Cellular Immunology Unit, Oxford) followed 
by tetramethylrhodamine B isothiocyanate-conjugated goat anti- 
mouse Ig antibody (Sera-lab, Crawley Down, England). In some 
experiments, ceils were isolated from the small intestine by enzyme 
digestion after the injection of FITC-labeled canine albumin and 
stained as described above. FITC-labded canine albumin was also 
injected intraintestinally into MLNX rats and bDC enriched and 
examined for the presence of antigen under the fluorescence mi- 
croscope. 
ELISA.  ELISA plates (Dynatech Dynal [UK], Merseyside, En- 
gland) were coated by adding antigen (OVA or HRP; 100/~g/ml) 
in PBS (50/~l/well) and storing at 4~  overnight. The plates were 
washed three times with PBS/Tween (Koch Light Laboratories, 
Haverhill, England), and 50/zl of 1% BSA was added for 30 min 
at 4~  to block nonspecific binding. After washing three times, 
fivefold dilutions of the serum to be assayed were added and the 
plates were incubated at 4~  for 30 min. Negative, positive,  and 
background wells were set up by adding negative serum, positive 
serum, or medium alone. 
To detect anti-OVA antibody, 50/zl sheep anti-rat igG or IgM 
(1:500 in PBS/Tween) was added after washing and the plates were 
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acid/phosphate buffer (pH 5), 50 #1 ofperoxidase-conjugated swine 
anti-sheep Ig (1:500 in PBS/Tween) was added and the plates were 
incubated for 30 rain at 4~  After three washes with 0.1 M citric 
acid/phosphate buffer, 50 #1 1,2-phenylenediamine (OPD; Dako, 
High Wycombe, England)  solution was added to each well and 
the plates were wrapped with foil and read at 405 nm in a ELISA 
reader (LKB Instruments,  Inc., Gaithersburg,  MD). 
To detect anti-HRP antibody, alkaline phosphatase-conjugated 
rabbit anti-rat IgG (Sigma Chemical Co.) was added to the wells 
and the plates were incubated for 30 min at 4~  After three washes 
with PBS-Tween, 50 #1 p-nitrophenyl phosphate (Sigma Chemical 
Co.) in 9.7% diethylamine was added into the wells, and after in- 
cubation plates were read at 405 nm in a ELISA reader. 
Results 
Orally Administered  Antigens Are Acquired by Intestinal L-DC. 
Lymphadenectomized, carmulated rats were given graded doses 
of OVA by gastric intubation or, for comparison, by intrain- 
testinal injection. TDL was collected overnight and DC were 
isolated by density gradient centrifugation. Different numbers 
of L-DC were added to sensitized spleen cells and prolifera- 
tion was measured by thymidine incorporation.  The results 
(a typical experiment is shown in Fig.  1) demonstrate that 
after doses of 1-10 mg, L-DC derived from the small intes- 
tine have acquired  antigen  and can present  it  to sensitized 
T  cells. L-DC from orally challenged rats stimulated a much 
lower response than intraintestinally challenged rats. When, 
however, the ability of such L-DC to prime T  cells in vivo 
was tested (see below), specific priming was seen with doses 
down to  1 mg. 
Fate of  Antigen after Intraintestinal Injection,  FITC-labeled 
canine albumin was injected intraintestinally,  and L-DC col- 
lected at intervals  over the next 48 h were examined for the 
presence of fluorescent label.  No labeled L-DC or other cells 
were seen.  Frozen sections of small intestine taken 1, 3, and 
6 h after injection,  and cell suspensions prepared from the 
lamina propria,  were stained for MHC class II or OX62,  an 
antibody that labels DC and probably "g/~ T cells,  but not 
macrophages,  in the lamina propria (21). Antigen was clearly 
present in some large MHC class II-negative cells, presumed 
to be macrophages,  but was not  seen  in OX62 + cells. 
In Vivo  Priming ofT Cells in Naive Rats by Antigen-bearing 
L-DC  L-DC, B cells, and T cells were enriched from normal 
XTDL  and  incubated  with  OVA (1  mg/ml)  for 3  h  and 
washed, or were enriched from XTDL after oral or intrain- 
testinal antigen administration.  Graded numbers of cells were 
Table  1.  Priming of Naive Rats with In Vitro OVATulsed 
Cells from XTDL 
Ag concentration  in  culture 
35 
30 
O  Intestinal  OVA-pulsed LDC + OVAL 
￿9  Oral OVA-pulsed LDC +  OVAL 
~z Oral OVA-pulsed LDC + HRPL 
r 
25 
20 
O 
r~  15 
10 
5  0------  -v  v 
i  i  i  i  t  f 
0  2  4  6  8  10  12 
Antigen  administered:  rag/rat 
Figure  1.  Acquisition of oral antigen by L-DC. PVG rats were cannu- 
]ated and given different doses of OVA intraintestinally or orally (by gas- 
tric intubation). 18 h later, L-DC were enriched and cultured with OVA or 
HRP-primed spleen cells for 108 h as described in Materials and Methods. 
Proliferation was measured by thymidine incorporation and expressed as 
gross cpm. (OVAL)  OVA-CFA-primed  spleen cells; (HRPL) HRP-CFA- 
primed spleen cells. This experiment has been repeated twice with similar 
results. 
Cells injected  Ag  100  #g  50 #g  25  #g  No Ag 
L-DC (2  x  103)  OVA  54,169  35,783  26,708  2,989 
HRP  6,424  1,689 
L-DC (2  x  104  )  OVA  20,039  13,526  490 
HRP  916  1,001 
L-DC (2  ￿  103  )  OVA  13,191  9,789  777 
HRP  536  489 
BC (2  x  106)  OVA  28,606  13,229  12,755  2,912 
HRP  1,618  2,750  3,063 
BC (2  x  10  s)  OVA  15,370  7,854  5,541  257 
HRP  1,246  1,649  1,744 
TC  (2  x  106)  OVA  6,649  5,011  1,634  838 
HRP  1,381  2,060  2,903 
TC  (2  x  10  s)  OVA  487  860  617  359 
HRP  312  769  971 
XTDL was collected from MLNX rats. L-DC were enriched to 70% 
purity by centrifugation over 14.5% Metrizamide, and B cells and T cells 
enriched by rosetting  as described in Materials and Methods (85-90% 
purity for B cells; 90-92%  for T cells). There were "~1-1.5%  L-DC 
in the B cell fraction as identified by morphology and Ia staining. L-DC, 
B cells, and T ceils were cultured with OVA (I mg/ml) for 3 h, washed 
three times, and injected into the footpads of naive rats. 10 d after im- 
munization, popliteal lymph node cells were prepared and cultured with 
OVA or HRP in different concentrations (100, 50 and 25/~g/ml) for 
120 h.  16 h  before harvesting,  [3H]TdR  was  added into  the  wells. 
Results are expressed as gross cpm. This experiment was performed three 
times with similar results. 
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Figure  2.  Ability of antigen-pulsed L-DC and B cells to prime naive 
rats. L-DC from MLNX rats and B cells from normal TDL were pulsed 
with OVA (1 mg/ml) and injected into the footpads of naive rats. 10 d 
later, popliteal lymph node cells were prepared and cultured with OVA 
(50 #g/ml) for 5 d and proliferation measured and expressed  as gross cpm. 
This experiment has been performed twice with similar results. 
injected into the footpads of naive rats.  10 d later, popliteal 
lymph node cells were cultured with OVA or HRP for 5 d, 
and proliferation was measured, 
Priming with In Vitro Pulsed Cells.  The results from L-DC 
pulsed in vitro show that both the L-DC and B cell fractions 
sensitized  specificaUy whereas T  cells were inert  (Table  1). 
500-2,000 L-DC in different experiments sensitized naive rats 
specifically, whereas at least 100 times more enriched B cells 
fraction were needed to initiate a similar response. DC con- 
tamination  in the B  cell fraction was 1-1.5%  as judged by 
morphology and Ia staining. To assess the role of DC in the 
Ag-pulsed B cell population from XTDL, we attempted to 
prime naive rats using Ag-pulsed B cells from normal TDL, 
which contains <0.1% DC. The results show that Ag-pulsed 
normal TDL B  cells are completely ineffective in sensitiza- 
tion (Fig. 2), and thus the only cells in XTDL able to sensi- 
tize naive rats  are DC. 
Priming with DC from Animals after In  Vivo Antigen Ad- 
ministration.  DC enriched  from XTDL  collected for 24 h 
after oral or intraintestinal  antigen  administration  were in- 
jected into naive rats,  and  10 d  later, popliteal lymph node 
cells were tested for specific sensitization.  The results show 
that L-DC from rats challenged via both routes are effective 
at all doses of antigen tested (Fig. 3). Intraintestinal antigen 
gave rise to larger responses than oral antigen but the differ- 
ences were  not  large. 
Antigen-pulsed Macrophages Cannot Prime Naive Rats.  Peri- 
toneal macrophages were cultured with OVA for 3 h. After 
washing,  they were injected into the footpads of naive rats. 
OVA-pulsed L-DC were used as a positive control. The results 
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Figure  3.  Ability of different doses of antigen to load bDC for priming. 
MLNX rats were cannulated and challenged with different doses of OVA 
(1, 10, and 20 mg/rat) orally or intraintestinaily. I.-DC were enriched and 
injected into the footpad of naive PVG rats (5  x  104/footpad). 10 d later, 
popliteal lymph node ceils were prepared  and cultured with OVA (50/~g/ml) 
for 5 d and proliferation measured and expressed as gross cpm. This ex- 
periment was performed three times with similar results. 
show that OVA-pulsed peritoneal macrophages were com- 
pletely unable to sensitize naive rats  (Table 2). 
Only Live L-DC Can Prime  Naive Rats.  OVA-pulsed L-DC 
were either fixed with glutaraldehyde or frozen and thawed 
on dry ice.  Fixed or killed L-DC were unable to stimulate 
a MLR  (data not  shown).  When  these cells were injected 
Table  2.  Comparison of OVA-pulsed Peritoneal Macrophages 
and L-DC in Priming Naive Rats 
Ag (50 t~g/ml) 
Cells injected  OVA  HILP  No Ag 
L-DC 
5  x  103  41,619  533  460 
5  x  102  39,399  483  540 
Macrophages 
5  x  104  492  218  427 
5  x  103  110  282  260 
Peritoneal macrophages were  obtained  as described in  Materials and 
Methods. L-DC were enriched from XTDL. Macrophages and L-DC 
were cultured with OVA (1 mg/ml) for 3 h, washed three times, and 
injected into the footpads of naive rats. 10 d later, popliteal lymph node 
cells were prepared and a proliferation assay  was carried out in the presence 
of OVA or HRP (50 #g/ml). This experiment was repeated once with 
similar results. 
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Figure 4.  Only live L-DC can prime naive rats. L-DC were pulsed with 
OVA (1 mg/ml) for 3 h and washed. Some OVA-L-DC were fixed with 
1% ghtaraldehyde  (GDA). Some  OVA-LDC  were  frozen  and thawed several 
times on dry ice. Normal OVA-L-DC, GDA-fixed  bDC dry ice-killed 
L-DC, and OVA in PBS were  injected  into the footpads  of naive  rats (2 x 
10S/footpad). 10 d later, proliferation  of popliteal lymph node  cells to OVA 
or HRP (50/*g/ml)  was measured. The results are expressed  as gross  cpm. 
This experiment was repeated twice with similar results. 
into the footpads of naive rats no significant sensitization was 
seen (Fig.  4). 
Sensitized T Cells Are CD4 + and MHC Class II Restricted. 
Popliteal lymph node cells from animals primed with antigen- 
pulsed L-DC were cultured with specific antigen in the pres- 
ence of mAbs to MHC class II (OX6), CD4 (W3/25), CD8 
(OX8) (22), and human C3b inactivator (INA) (OX21) (23). 
The results show that anti-MHC class II or anti-CD4 anti- 
bodies but not anti-CD8 or anti-human C3b INA inhibited 
the proliferation of sensitized lymph node cells to OVA (Fig. 5). 
L-DC Present Antigen Directly to Naive T Cells In Vim  Al- 
though indirect evidence (e.g., that only live L-DC are able 
to sensitize naive rats)  suggests that antigen-pulsed L-DC 
may present Ag directly to host T cells, it was possible that 
host DC obtained antigen from donor L-DC for presenta- 
tion to host T  cells.  To address this question, L-DC from 
PVG-RT1  u or congenic PVG-RT1  c rats, which differ at the 
MHC,  were either pulsed in vitro with OVA or obtained 
from PVG-RT1  u or PVG-RT1  c rats that had been injected 
with OVA intraintestinally. These L-DC were injected into 
footpads of (PVG-RT1  u  x  PVG-RT19F, rats.  10 d  later, 
draining popliteal lymph node cells were depleted of B cells 
and MHC class II-bearing cells and cultured with irradiated 
PVG-RT1  c or PVG-RT1  u spleen cells in the presence of OVA 
or HRP. The results show that the responses were restricted 
to the MHC class II molecules on the immunizing L-DC 
(Table 3). T cells from F, animals injected with Ag-bearing 
L-DC from PVG-RT1  c rats respond to OVA in the presence 
of PVG-RTV spleen cells but not PVG-RT1  ~ spleen cells. 
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Figure  5.  MHC class II restriction  and CD4 dependence  of  primed  cells. 
Popliteal lymph  node  cells of  rats immunized  with OVA-pulsed  I,  DC were 
cultured with OVA (50 #g/ml) in the presence  of different  mAbs (final 
concentration, 5 ~g/ml) for 5 d. Proliferation  of popliteal lymph node 
cells was measured  and expressed  as gross cpm. OXS, anti-CD8; W3/25, 
anti-CD4; OX6, anti-MHC class II; OX21, anti-human c3b INA. This 
experiment has been performed twice with similar results. 
Similarly, T cells from F, animals injected with Ag-bearing 
L-DC from PVG-RT1  u rats respond to OVA in the presence 
of PVG-RT1  u spleen cells but not PVG-RT1  c spleen cells. 
L-DC pulsed in vitro or from intraintestinally challenged rats 
(Table 3) gave similar results.  These results show clearly that 
donor L-DC present OVA directly to host T  cells. 
Antigen-bearing L-DC Do Not Induce Primary Antibody Re- 
sponses.  The experiments mentioned above show that in vitro 
or in vivo antigen-pulsed L-DC could directly sensitize T 
cells in a naive rat. To determine whether antigen-bearing 
L-DC were able to induce an antibody response, naive rats 
were immunized with orally or intraintestinally challenged 
L-DC, in vitro antigen-pulsed L-DC,  soluble antigens,  or 
antigens emulsified with CFA. 10 d after priming, sera were 
obtained and the rats were boosted with soluble antigens sub- 
cutaneously (OVA or HRP).  10 d after boosting, rats were 
bled again to obtain sera. Serum antibody levels were mea- 
sured using an ELISA technique. The results show that nei- 
ther in vitro nor in vivo antigen-pulsed L-DC were able to 
induce a primary response. In vitro OVA-pulsed BC or peri- 
toneal macrophages were similarly ineffective (Table 4). How- 
ever, after boosting with soluble antigens, weak IgG anti- 
body responses were present in all rats that had been primed 
with antigen-bearing L-DC (Table 4). 
Discussion 
The uptake, transport, and presentation of antigen in vivo 
are crucial stages in the initiation of immune responses but Table  3.  Ag-bearing L-DC Present Ag Directly to Host T  Cells 
F1 T cells  APC  OVA  HRP  No Ag 
L-DC pulsed with OVA in vitro 
L-DC from rats challenged with 
OVA intraintestinaUy 
cF1T  cAPC 
cFIT  uAPC 
cFIT 
cFtT 
uFtT  uAPC 
uF1T  cAPC 
uFIT 
uF1T 
cF1T  cAPC 
cF1T  uAPC 
cFIT 
cFIT 
uFtT  uAPC 
uF1T  cAPC 
uF1T 
uF1T 
42,577  5,995 
9,156  637 
3,855 
25,076  4,431 
4,479  1,438 
5,911 
15,941  2,360 
1,412  214 
600 
16,388  1,848 
1,743  263 
1,140 
880 
330 
630 
330 
L-DC from either PVG-RTlc or PVG-RT1  u rats were cultured with OVA (1 mg/ml) for 3 h, washed, and injected (2  x  104/leg) into the foot- 
pads of naive F1 rats (PVG-RT1  c x  PVG-R.TI~). L-DC from rats that had been injected with OVA (10 mg/ml) intraintestinally  were injected 
into the footpads of naive F1 rats (PVG-RT1  c x  PVG-RTlu). 10 d later, T cells were enriched from popliteal lymph node cells of those L-DC- 
injected rats, as described in Materials and Methods, and cultured with OVA or HRP in the presence of irradiated spleen cells from PVG-RT1  c 
or PVG-P,  T1  u rats for ".,120 h. [3H]TdR was added to the cultures 16 h before harvesting. The results are expressed as gross cpm. Concentration 
of Ag in culture is 50/Lg/ml. Number of spleen cells as APC is 10S/well; number of Ft T cells is 10S/welt. cF1T: T cells enriched from F1 rats 
that had been injected with Ag-pulsed L-DC from PVG-RTlc; uF1T, T cells enriched from F1 rats that had been injected with Ag-pulsed L-DC 
from PVG-RTlu; cAPC, spleen cells from PVG-RTlc rats; uAPC, spleen cells from PVG-RT1  ~ rats. 
understanding of these processes is very limited. The rational 
design of vaccines, however,  depends on a full comprehen- 
sion of in vivo antigen handling. What is known of the func- 
tions of DC suggests that they may be the major APC in- 
volved in the initiation of primary in vivo responses, and there 
is considerable evidence that DC can acquire antigen in pe- 
ripheral tissues  and transport it for presentation to T  cells 
in secondary lymphoid tissue (10-13). There is, however, little 
information on antigen handling at mucosal surfaces, despite 
these being the major sites for pathogen entry. 
In this paper we examine the function of DC in the small 
intestine in the acquisition of antigens present in the intes- 
tinal lumen. We have previously shown that DC in the in- 
testinal wall acquire soluble protein antigens injected directly 
into the intestinal lumen, and within a few hours, migrate 
into peripheral lymph, carrying antigen in a form that can 
be presented to sensitized T cells in an MHC class II-restricted, 
CD4-dependent manner (15). In this paper we extend these 
results to examine the handling of orally administered an- 
tigen and the ability of antigen-bearing APC to initiate pri- 
mary responses  in vivo. 
Several different cell types expressing MHC class II can 
present antigens to activated T cells (3, 4, 9), but virgin or 
resting rodent T  cells are far more responsive  to antigens 
presented by DC than by other APC for both allogeneic and 
syngeneic conventional responses in vitro (11, 24, 25).  It is, 
however, important to show that antigen-bearing APC can 
also stimulate primary responses in vivo. Several groups have 
shown that after the injection of antigen-bearing APC, the 
recipient animals become sensitized (11), but it is not pos- 
sible to exclude presentation of antigen by host APC in these 
experiments. Direct presentation has, however, been shown 
by Inaba et al. (26),  who found that after the injection of 
DC, either pulsed in vitro or in vivo, from one parental strain 
into F1 recipients,  T cells from these recipients gave a sensi- 
tized response  only to antigen presented on APC from the 
strain from which the injected DC were obtained. We have 
similarly shown that after injection of F1 rats with parental 
strain L-DC, either pulsed in vitro or from animals injected 
intraintestinally with antigen, the sensitization of T cells from 
the draining nodes is restricted to the MHC of the injected 
L-DC. We have also shown that only live DC are able to 
prime naive animals, and that antigen-pulsed B cells or peri- 
toneal macrophages are completely inert in priming. Thus, 
it is clear that after oral or intraintestinal administration, DC 
in the wall of the intestine acquire  antigen and are able to 
prime naive T cells in lymph nodes in vivo. Surprisingly small 
numbers of DC are required to initiate detectable responses 
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Antigen-bearing L-DC 
Primary  Secondary 
Priming  IgG  IgM  IgG  IgM 
Oral  L-DC  (OVA)  -  -  1/25  - 
Intestinal  L-DC  (OVA)  -  -  1/25  - 
Vitro  L-DC  (OVA)  -  -  1/25 
Oral  L-DC  (HRP)  -  -  1/5  - 
Intestinal  L-DC  (HRP)  -  -  1/25  - 
Vitro  L-DC  (HKP)  -  -  1/25  - 
Vitro-pulsed BC  (OVA)  -  -  ND  ND 
Vitro-pulsed  Mq~  (OVA)  -  ND  ND  - 
Soluble  OVA  -  -  - 
Soluble  HRP  .... 
OVA-CFA  1/3,125  1/625  1/15,625  1/625 
HRP-CFA  1/625  ND  1/15,625  ND 
Naive PVG rats (three to four rats in a group) were immunized with 
cells from oral or intraintestinally antigen-challenged animals, cells pulsed 
in vitro with antigens, or antigens emulsified in CFA. 10 d after immu- 
nization, rats were boosted with soluble antigens subcutaneously. Sera 
were obtained from rats 10 d after immunization and 10 d after a boosting 
injection. Negative serum was from normal PVG rats. Serum anti-OVA 
or HRP antibody isotypes were measured by ELISA as described in Materi- 
als and Methods. Positive titers were defined as those whose OD value 
was higher than the OD of the negative control plus 2 SD. Oral L-DC, 
L-DC from rats that had been challenged with antigen (OVA or HRP; 
10 mg) via intragastric tube. Intestinal L-DC, L-DC from rats that had 
been challenged with OVA  or  HRP  intraintestinally (10  mg).  Vitro 
pulsed, cells pulsed with OVA or HRP in vitro I mg/ml); -CFA, Anti- 
gen in PBS emulsified with an equal volume of CFA. 
in vivo, the injection of as few as 500 in vitro antigen-pulsed 
DC is sufficient to give significant sensitization. Given that 
only a small percentage of injected DC are likely to migrate 
to the node (27), the process of sensitization is remarkably 
efficient. In vivo priming with antigen-pulsed DC is a more 
sensitive assay for antigen than the in vitro stimulation of 
proliferation in sensitized T  cells in that after the oral ad- 
ministration of I mg of OVA, L-DC collected over the next 
24  h  are able to  sensitize naive rats but  do not  stimulate 
significant proliferation of sensitized T  cells. 
The site at which L-DC acquire antigen from the gut lumen 
is not known. M  cells in Peyer's patches are specialized  for 
antigen transport  (28),  but proteins can also cross normal 
epithelia. DC are present in Peyer's patches (29) and lamina 
propria (6), and L-DC could enter lymph from either or both 
sites. Endocytosis of antigen by DC can be shown after cul- 
ture in vitro for long periods with relatively high concentra- 
tions of fluorescent antigen (26), but in vivo DC are prob- 
ably exposed to relatively low concentrations for short periods, 
explaining our inability to detect antigen visually in DC in 
lamina propria,  Peyer's patches,  or lymph. 
In many models, orally administered antigen leads to the 
development of specific systemic tolerance. The mechanisms 
hypothesized to underly oral tolerance include the genera- 
tion of suppressor T cells (30) and circulating immune com- 
plexes (31), while a recent report has suggested the involve- 
ment of APC expressing I-J determinants (8).  Others have 
suggested that presentation of enteric antigens by MHC class 
II-expressing epithelial cells may selectively generate suppressor 
cells (7). Why orally administered antigen should have these 
effects is not known, but Michael (32) has shown that whereas 
giving BSA orally induces tolerance in mice, intraintestinal 
injection leads to sensitization,  but that peptides derived from 
the antigen after peptic digestion are tolerogenic on intrain- 
testinal injection. Our results show that orally administered 
antigen is acquired by L-DC in a manner very similar to an- 
tigen injected intraintestinally. At all doses tested, down to 
I  rag, L-DC collected after antigen administration by both 
routes are able to prime T cells in naive recipients although 
responses after oral administration are somewhat smaller. The 
antigen acquired by L-DC must be absorbed in the small in- 
testine in both cases, as the lymph nodes draining the stomach 
are not removed during lymphadenectomy. Thus, orally ad- 
ministered antigens are made available to the immune system 
in a form able to stimulate virgin CD4 + T  cells,  and any 
explanation of oral tolerance must take account of the pres- 
ence of these highly immunostimulatory APC in mesenteric 
nodes. 
We have shown that footpad injection of antigen-pulsed 
L-DC does not induce detectable levels of circulating anti- 
body and that antigen-pulsed macrophages and B ceils are 
similarly ineffective in stimulating primary antibody synthesis. 
However, when L-DC-primed rats are boosted with soluble 
antigens, weak secondary antibody responses can be detected. 
It is well recognized that small doses of antigen tend to stimu- 
late cell-mediated responses selectively (33)  and the L-DC 
that induce T cell sensitization do not carry directly detect- 
able amounts of antigen.  It is also likely that the bulk of 
the antigen acquired by L-DC is processed and expressed in 
the form of peptides and is therefore unable to stimulate an 
antibody response against whole native antigen. That weak 
responses are observed after challenge with soluble antigen 
may reflect the ability of CD4 + T cells, sensitized in the pri- 
mary response, to give increased levels of help to B cells. 
Recently, Sornasse et al.  (34)  have shown that antigen- 
pulsed spleen DC can induce a primary antibody response 
in vivo.  Although at first sight this seems in conflict with 
our results, they detected antibody only after boosting with 
the same soluble antigen 5 d later. The antibodies they mea- 
sured were from sera taken 7 d after boosting. Thus, the an- 
tibody they measured may well reflect a secondary response. 
We conclude that orally administered antigen is acquired 
efficiently in an immunostimulatory form by intestinal DC 
and that these early stages of the initiation of a primary im- 
mune response do not differ significantly from those that 
follow parenteral immunization. 
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